News
Alder to start raising new fund in H2 2021
Sponsor is currently investing from Alder II, which closed on its hard-cap of SEK 1.5bn in 2019
BGF appoints Isherwood and Strang to board
Kris Isherwood is currently CFO of Eight Roads and Jim Strang is chairman of Hamilton Lane
Kline Hill Partners' third secondaries fund now 40% deployed
Kline Hill Partners Fund III held a second and final close on its $450m hard-cap in April
General Atlantic promotes two
Melis Kahya Akar becomes managing director and Caroline Woodworth is promoted to principal
Cavendish promotes Farrugia to managing partner
Farrugia has also held positions at Strata Partners and Close Brothers Corporate Finance
GP Profile: EMH aims for three deals per year following close of second fund
EMH co-founder and managing partner Maximilian Kuss speaks to Unquote about the fundraising process and EMH's deal-making plans
Ely Place appoints Leppla as partner
Leppla will focus on assisting private equity, credit, infrastructure and venture GPs raise capital from institutions
Deutsche Beteiligungs AG announces annual results
While 2019-2020 saw DBAG's NAV fall by 5.8%, the GP expects to increase PE investments in the coming years
Capita in exclusive talks with Montagu to sell its ESS division
Capita engaged with Goldman Sachs in June 2020 to sell the asset for around ТЃ500-700m
MLL auction process begins – report
Munich Leukemia Laboratory could generate a valuation of 11-12x, Mergermarket reports
GP-backed Diaverum scraps plans for IPO
GP said indications received did not fully reflect the fundamental value of the business
Deutsche Beteiligungs AG announces supervisory board changes
Tom Alzin and Jannick Hunnecke will join, while Rolf Scheffels is to leave when his term ends
Duff & Phelps appoints Bretag
Frank Bretag joins from Georgieff Capital Advisors and focuses on the industrial goods sector
SR One set to deploy $500m fund following GSK spin-out
CEO Simeon George tells Unquote that the firm is seeing early-stage and later-stage opportunities
Klar Partners hires Kuehne
Vera Kuehne joins the GP's London-based team
Investindustrial's SPAC trades on NYSE
Company plans to acquire European businesses with an enterprise value in the range of $1-5bn
Alder to exit Finnish company Aidon in Q1 2021 – report
GP acquired a majority stake in the company in 2013, alongside 2VK Invest, Tesi and key employees
CVC, Advent, FSI to buy Serie A in €1.7bn deal
Consortium will acquire a 10% stake in a new media company, which will manage Serie A's broadcasting rights
Mercia-backed Abingdon Health files for IPO
Abingdon Health was in discussions with potential investors for an IPO to raise around ТЃ100m
C5 to hold double close in December 2020
Launched in February 2020, the firm's impact fund has made two investments, including Enveil
Novalis Biotech aims for January second close for new €25m fund
Belgian VC Novalis held a first close on €8m for its second fund on 8 November
Aberdeen secondaries fund on track for early 2021 final close
Secondary Opportunities Fund IV has raised more than half of its $500m target
Sale of EQT-owned Fertin Pharma to launch in Q1 2021
GP is aiming to close the deal before the second half of 2021
Omers considers sale of ERM for £2.5bn – report
Omers Private Equity acquired ERM from Charterhouse for an enterprise value of $1.7bn in June 2015